Expression profiling and putative mechanisms of resistance to doxorubicin of human lung cancer cells

Doklady Biochemistry and Biophysics

Volumn 430, Issue 1, 2010, Pages 20-23

  Kashkin, K N ^a   Musatkina, E A ^b   Komelkov, A V ^b   Favorskaya, I A ^b   Trushkin, E V ^c   Shleptsova, V A ^c   Sakharov, D A ^c   Vinogradova, T V ^a   Kopantzev, E P ^a   Zinovyeva, M V ^a   Kovaleva, O V ^b   Zborovskaya, I B ^b   Tonevitsky, A G ^c   Sverdlov, E D ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c Institute of Physical Culture and Athletics   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; TUMOR MARKER;

ARTICLE; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 77649208480     PISSN: 16076729     EISSN: None     Source Type: Journal    
DOI: 10.1134/S1607672910010072     Document Type: Article

References (15)

1. Non-Small Cell Lung Cancer Collaborative Group, Cochrone Database Syst. Rev., 2000, issue 2, art. no. CD002139.
2. Perez-Soler, R, Oncogene, 2009, vol. 28, Suppl. 1, pp. S38-S45.
3. Ds'Arpa, P. and Liu, L. F., Biochim. Biophys. Acta, 1989, vol. 989, pp. 163-177.
4. Sinha, B. K. and Mimnaugh, E. G., Free Radic. Biol. Med., 1990, vol. 8, pp. 567-581.
5. Lorenzo, E., Ruiz-Ruiz, C, Quesada, A. J., et al., J. Biol. Chem., 2002, vol. 277, pp. 10883-10892.
6. Fujiwara, Y., Kawada, K., Takano, D., et al., Biochem. Biophys. Res. Commun., 2006, vol. 340, pp. 560-566.
7. Spallarossa, P., Altieri, P., Garibaldi, S., et al., Cardiovasc. Res., 2006, vol. 69, pp. 736-745.
8. Stavrovskaya, A. A., Biochemistry (Mosc.), 2000, vol. 65, pp. 95-106.
9. Burgess, D. J., Doles, J., Zender, L., et al., Proc. Natl. Acad. Sci. USA, 2008, vol. 105, pp. 9053-9058.
10. Okada, Y., Tosaka, A., Nimura, Y., et al., Gene, 2001, vol. 272, pp. 141-148.
11. Hembruff, S. L., Laberge, M. L., Villeneuve, D. J., et al., BMC Cancer, 2008, vol. 8, p. 318.
12. Veitch, Z. W., Guo, B., Hembruff, S. L., et al., Pharmacogen. Genom., 2009, vol. 19, pp. 477-488.
13. Alley, M. C., Scudiero, D. A., Monks, A., et al., Cancer Res., 1988, vol. 48, pp. 589-601.
14. Tsai, C. M., Chang, K. T., Wu, L. H., et al., Cancer Res., 1996, vol. 56, pp. 206-209.
15. Staunton, J. E., Slonim, D. K., Soller, H. A., et al., Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 106787-10792.